Reshaping the Tumor Stroma for Treatment of Pancreatic Cancer

被引：161
作者：
Vennin, Claire [1 ,2 ,3 ]
Murphy, Kendelle J. [1 ,2 ,3 ]
Morton, Jennifer P. [4 ]
Cox, Thomas R. [1 ,2 ,3 ]
Pajic, Marina [1 ,2 ,3 ]
Timpson, Paul [1 ,2 ,3 ]
机构：
[1] Garvan Inst Med Res, Sydney, NSW, Australia
[2] Kinghorn Canc Ctr, Sydney, NSW, Australia
[3] Univ New South Wales, Fac Med, St Vincents Clin Sch, Sydney, NSW, Australia
[4] Beatson Inst Canc Res, Canc Res UK, Glasgow, Lanark, Scotland
来源：
GASTROENTEROLOGY | 2018年 / 154卷 / 04期
基金：
英国医学研究理事会; 澳大利亚研究理事会;
关键词：
Pancreatic Cancer; Stromal Remodeling; Invasion; Metastasis; Diagnostic Tool; Patient-Derived Models; DUCTAL ADENOCARCINOMA; THERAPEUTIC RESPONSE; TISSUE HOMEOSTASIS; HIGH-THROUGHPUT; CELL DORMANCY; MOUSE MODELS; T-CELLS; INHIBITION; FIBROBLASTS; PATIENT;
D O I：
10.1053/j.gastro.2017.11.280
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Pancreatic cancer is accompanied by a fibrotic reaction that alters interactions between tumor cells and the stroma to promote tumor progression. Consequently, strategies to target the tumor stroma might be used to treat patients with pancreatic cancer. We review recently developed approaches for reshaping the pancreatic tumor stroma and discuss how these might improve patient outcomes. We also describe relationships between the pancreatic tumor extracellular matrix, the vasculature, the immune system, and metabolism, and discuss the implications for the development of stromal compartment-specific therapies.
引用
收藏
页码：820 / 838
页数：19
相关论文
共 186 条
  • [1] Tumor macrophages are pivotal constructors of tumor collagenous matrix
    Afik, Ran
    Zigmond, Ehud
    Vugman, Milena
    Klepfish, Mordehay
    Shimshoni, Elee
    Pasmanik-Chor, Metsada
    Shenoy, Anjana
    Bassat, Elad
    Halpern, Zamir
    Geiger, Tamar
    Sagi, Irit
    Varol, Chen
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2016, 213 (11) : 2315 - 2331
  • [2] Metastatic progression is associated with dynamic changes in the local microenvironment
    Aiello, Nicole M.
    Bajor, David L.
    Norgard, Robert J.
    Sahmoud, Amine
    Bhagwat, Neha
    Pham, Minh N.
    Cornish, Toby C.
    Iacobuzio-Donahue, Christine A.
    Vonderheide, Robert H.
    Stanger, Ben Z.
    [J]. NATURE COMMUNICATIONS, 2016, 7
  • [3] High prevalence of mutant KRAS in circulating exosome-derived DNA from early-stage pancreatic cancer patients
    Allenson, K.
    Castillo, J.
    San Lucas, F. A.
    Scelo, G.
    Kim, D. U.
    Bernard, V.
    Davis, G.
    Kumar, T.
    Katz, M.
    Overman, M. J.
    Foretova, L.
    Fabianova, E.
    Holcatova, I.
    Janout, V.
    Meric-Bernstam, F.
    Gascoyne, P.
    Wistuba, I.
    Varadhachary, G.
    Brennan, P.
    Hanash, S.
    Li, D.
    Maitra, A.
    Alvarez, H.
    [J]. ANNALS OF ONCOLOGY, 2017, 28 (04) : 741 - 747
  • [4] Stromal disrupting effects of nab-paclitaxel in pancreatic cancer
    Alvarez, R.
    Musteanu, M.
    Garcia-Garcia, E.
    Lopez-Casas, P. P.
    Megias, D.
    Guerra, C.
    Munoz, M.
    Quijano, Y.
    Cubillo, A.
    Rodriguez-Pascual, J.
    Plaza, C.
    de Vicente, E.
    Prados, S.
    Tabernero, S.
    Barbacid, M.
    Lopez-Rios, F.
    Hidalgo, M.
    [J]. BRITISH JOURNAL OF CANCER, 2013, 109 (04) : 926 - 933
  • [5] Obstacles Posed by the Tumor Microenvironment to T cell Activity: A Case for Synergistic Therapies
    Anderson, Kristin G.
    Stromnes, Ingunn M.
    Greenberg, Philip D.
    [J]. CANCER CELL, 2017, 31 (03) : 311 - 325
  • [6] [Anonymous], J CLIN ONCOL S
  • [7] [Anonymous], J NATL CANC I
  • [8] [Anonymous], BIOMED RES INT
  • [9] [Anonymous], GUT
  • [10] [Anonymous], J NUCL MED
12345678910